FDA Drug Risk Evaluation Division Directors Are Honig, Rodriguez
Executive Summary
The directors of FDA's two drug risk evaluation divisions within the new Office of Post-Marketing Drug Risk Assessment are Peter Honig, MD, and Evelyn Rodriguez, MD.